findmyKOL
Clinical trialNCT03214601Active, not recruitingInterventional

Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System

SponsorBolton MedicalEnrollment30Aneurysm, RupturedAortic AneurysmThoracic Aorta Aneurysm
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to conduct an early clinical evaluation of the Relay Branch System, which will provide initial insight into the clinical safety and function of the device. This Early Feasibility Study (EFS) will assess the safety and effectiveness of the device at the index procedure and at 30-day follow-up. The study will evaluate the delivery and deployment of the device, patency of branches and branch vessels, and exclusion of the aortic pathology. The data will help determine if modifications need to be made to the device, the procedural steps, operator technique, or the indications for use.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Southern California

    Los Angeles, California, United States

  • University of Florida

    Gainesville, Florida, United States

  • Emory University

    Atlanta, Georgia, United States

  • University of Maryland

    Baltimore, Maryland, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Barnes Jewish Hospital at Washington University

    St Louis, Missouri, United States

  • Columbia University Medical Center

    New York, New York, United States

  • Duke University

    Durham, North Carolina, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Hospital of the University of Pennsylvania/penn Presbyterian

    Philadelphia, Pennsylvania, United States

  • Baylor College of Medicine

    Houston, Texas, United States

  • Baylor Scott and White Research Institute

    Plano, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Dec 2017
Primary completion
18 Sept 2023
Completion
31 Aug 2028
Last update posted
31 May 2025
Registered enrollment
30
Registry id
NCT03214601

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.